Intermittent Fasting Aids Some Outcomes for Postmenopausal Women With RA
By Lori Solomon HealthDay Reporter
.jpg?width=1200)
FRIDAY, Jan. 31, 2025 -- Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online Jan. 18 in Scientific Reports.
Aryan Tavakoli, from the School of Nutritional Sciences and Dietetics at the Tehran University of Medical Sciences in Iran, and colleagues randomly assigned 44 postmenopausal women (with overweight or obesity) with rheumatoid arthritis to either following a 16:8 intermittent fasting diet or their usual diet.
The researchers found that the intermittent fasting group showed significant decreases in serum malondialdehyde levels and neutrophil-to-lymphocyte ratio and increased catalase levels versus the control group. There were also significant decreases seen in the liver enzymes aspartate transaminase and alanine transaminase in the intermittent fasting group.
"In conclusion, these findings indicate that intermittent fasting may offer a valuable nonpharmacological approach to managing rheumatoid arthritis in this specific population, addressing both the primary disease symptoms and associated metabolic complications," the authors write. "While further research is needed to fully elucidate the mechanisms and long-term effects, this study provides strong evidence for the potential of intermittent fasting as an adjunct therapy in the management of rheumatoid arthritis, particularly in postmenopausal women who are overweight and obese."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Plant-Based Diet Tied to Weight Loss, Fewer Hot Flashes in Postmenopausal Women
THURSDAY, June 5, 2025 -- A plant-based diet rich in soy, regardless of the level of processing, may benefit both hot flash and weight management in postmenopausal women...
ASCO: Elinzanetant Cuts Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
TUESDAY, June 3, 2025 -- For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a...
Earlier Natural Menopause Risk Increased for Women in Socially Vulnerable Neighborhoods
THURSDAY, May 29, 2025 -- Women residing in U.S. neighborhoods with high social vulnerability have a higher risk for earlier natural menopause, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.